Trials / Not Yet Recruiting
Not Yet RecruitingNCT07389304
[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]
[EFFECTS OF SELECTED STATINS ON CARDIOVASCULAR PARAMETERS IN HEALTHY VOLUNTEERS: A RANDAMOZIED PHASE I CLINICAL TRIAL]
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shaheed Benazir Bhutto University Sheringal Dir Upper · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
This study is a Phase I randomized clinical trial aiming to investigate the short-term effects of three commonly prescribed statins i.e (Atorvastatin, Rosuvastatin, and Simvastatin) at different dose levels i.e lo,median and high doses on cardiovascular parameters i.e Blood pressure and ECG morphology in healthy volunteers. The study will assess changes in blood pressure and ECG morphology following two days of statin administration under controlled conditions.
Detailed description
The goal of this study is to evaluate the effects of these three statins on the cardiovascular parameters in a dose-dependent manner. In this Phase 1 clinical trial we will enroll healthy volunteers who will be randomized to receive one of three statins at low, moderate, or high doses for two days. .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin (5mg, 20mg, 40mg) | The Rosuvastatin (5mg, 20mg, 40mg) group participants will be given the drug orally OD for two days |
| DRUG | Atorvastatin (10mg, 20mg, 40mg) | The Atorvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days |
| DRUG | Simvastatin (10mg, 20mg, 40m | The Simvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-12-30
- Completion
- 2027-02-20
- First posted
- 2026-02-05
- Last updated
- 2026-02-05
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07389304. Inclusion in this directory is not an endorsement.